Brenda McCabe

Versatope Therapeutics, Inc. is an immuno-therapeutic company based in Lowell, MA. The private company harnesses a customized biotechnology platform to deliver immunity using state-of-the-art synthetic biology and bioinformatics. The company customizes exosome-like vesicles made from probiotics to display targets in a 3D context that activates potent immunity. The company's lead vaccine candidate addresses the need for improved, effective universal influenza vaccines to prevent influenza and other emerging infectious diseases, such as the current COVID-19. The company was founded in 2017 by Christopher Locher and Dave Putnam, and Christopher Locher has been the CEO since 2017.

Natraceutical SA engages in the research and development of naturally-sourced functional/active ingredients and nutritional complements for the foodstuffs, pharmaceutical and cosmetics sectors. It streamlines its industrial activity through two divisions, the Ingredients Division and the Nutritional Supplements Division, with the purpose of contributing to the prevention of diseases and improving quality of life through nutrition. It was founded on June 1, 1993 and is headquartered in Valencia, Spain.